Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating fr

StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note published on Monday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 1.4 % Diffusion Pharmaceuticals stock opened at $3.88 on Monday. The business has a 50-day simple moving average of $4.14 and a 200 […]

Related Keywords

, Diffusion Pharmaceuticals Inc , News Ratings For Diffusion Pharmaceuticals Daily , Jpmorgan Chase Co , Diffusion Pharmaceuticals Stock Down , Diffusion Pharmaceuticals Company Profile , Diffusion Pharmaceuticals , Nasdaq , Institutional Investors Weigh In On Diffusion Pharmaceuticals , Get Rating , Pharmaceuticals Stock Down , Trans Sodium Crocetinate , Diffusion Pharmaceuticals Daily , Nasdaq Dffn , Dffn , Medical , Initiated Coverage , Stocknews Com ,